Volume 138, Issue 7, Pages (June 2010)

Slides:



Advertisements
Similar presentations
CBG metaprotein composition shown in Figure 2. Associations also found between the IL28B rs genotype and SVR (p = 5.06×10 -5 ) and between CBG.
Advertisements

Volume 150, Issue 2, Pages e6 (February 2016)
Volume 149, Issue 6, Pages (November 2015)
Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin.
Volume 146, Issue 2, Pages e6 (February 2014)
A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection 
Volume 139, Issue 4, Pages (October 2010)
Volume 137, Issue 3, Pages e1 (September 2009)
Volume 131, Issue 2, Pages (August 2006)
Volume 147, Issue 1, Pages (July 2014)
Volume 139, Issue 5, Pages e1 (November 2010)
Covering the Cover Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
Volume 139, Issue 4, Pages (October 2010)
Volume 153, Issue 4, Pages (October 2017)
Outcomes Among Living Liver Donors
Volume 139, Issue 1, Pages e18 (July 2010)
Covering the Cover Gastroenterology
Peginterferon alfa-2b plus ribavirin for chronic hepatitis
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 140, Issue 3, Pages e10 (March 2011)
Volume 142, Issue 4, Pages (April 2012)
Volume 154, Issue 4, Pages e1 (March 2018)
Covering the Cover Gastroenterology
Covering the Cover Gastroenterology
Volume 155, Issue 4, Pages (October 2018)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 150, Issue 4, Pages (April 2016)
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Volume 155, Issue 5, Pages e2 (November 2018)
Volume 141, Issue 5, Pages (November 2011)
Volume 146, Issue 2, Pages e6 (February 2014)
Volume 139, Issue 4, Pages e2 (October 2010)
Anouk Dev, Keyur Patel, Andrew Conrad, Lawrence M. Blatt, John G
Volume 152, Issue 3, Pages e4 (February 2017)
Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients  Vincent G. Bain, Kelly D.
Volume 142, Issue 6, Pages (May 2012)
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 123, Issue 4, Pages (October 2002)
Volume 138, Issue 1, Pages e2 (January 2010)
Rafael Esteban, Maria Buti  Gastroenterology 
Time Trends of Ulcer Mortality in Europe
Volume 140, Issue 7, Pages (June 2011)
Constance E. Ruhl, James E. Everhart  Gastroenterology 
Volume 150, Issue 7, Pages (June 2016)
Lisa I. Backus, Derek B. Boothroyd, Barbara R
Covering the Cover Gastroenterology
Volume 132, Issue 1, Pages 5-6 (January 2007)
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Genetic Factors and Hepatitis C Virus Infection
Volume 149, Issue 6, Pages (November 2015)
Volume 139, Issue 6, Pages (December 2010)
Volume 139, Issue 5, Pages e3 (November 2010)
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Volume 130, Issue 6, Pages (May 2006)
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Hepatitis C treatment in patients with kidney disease
Covering the Cover Gastroenterology
Volume 156, Issue 4, Pages (March 2019)
Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection  Harald Farnik, Christian M. Lange,
Volume 130, Issue 7, Pages (June 2006)
Volume 145, Issue 5, Pages e3 (November 2013)
Volume 147, Issue 6, Pages (December 2014)
Covering the Cover Gastroenterology
Volume 148, Issue 1, Pages (January 2015)
Induction Pegylated Interferon Alfa-2b in Combination With Ribavirin in Patients With Genotypes 1 and 4 Chronic Hepatitis C: A Prospective, Randomized,
An Unusual Cause of Life-Threatening Upper Gastrointestinal Bleeding
Presentation transcript:

Volume 138, Issue 7, Pages 2307-2314 (June 2010) Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin  Jeanette J. McCarthy, Josephine H. Li, Alexander Thompson, Sunil Suchindran, Xiang Qian Lao, Keyur Patel, Hans L. Tillmann, Andrew J. Muir, John G. McHutchison  Gastroenterology  Volume 138, Issue 7, Pages 2307-2314 (June 2010) DOI: 10.1053/j.gastro.2010.02.009 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Flow diagram illustrating the selection of subjects from the Duke database for analysis. Gastroenterology 2010 138, 2307-2314DOI: (10.1053/j.gastro.2010.02.009) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Association between rs12979860 genotype and PEG-IFN/RBV treatment response in Caucasian and African American chronic HCV patients from our cohort. (A) Caucasians, (B) African Americans. Numbers with SVR out of all with that genotype are shown below each rs12979860 genotype. Chi-squared P values for Caucasians are adjusted for age, sex, HCV genotype, treatment history, and fibrosis. P values in African Americans are from the Fisher exact test and are not adjusted because of the small sample sizes. Gastroenterology 2010 138, 2307-2314DOI: (10.1053/j.gastro.2010.02.009) Copyright © 2010 AGA Institute Terms and Conditions

Figure 3 Effect of rs12979860 genotype on 3-level treatment outcome in Caucasian chronic HCV patients treated with PEG-IFN/RBV. Adjusted odds ratios (adj. or) and 95% confidence intervals are for rs12979860 CC vs CT/TT genotype comparing SVRs with relapsers, and relapsers with end-of-treatment nonresponders (nr), while controlling for age, sex, HCV genotype, treatment history, and fibrosis score. The P value shown is for the effect of the rs12979860 CC genotype on 3-level treatment response in multinomial regression analysis. Gastroenterology 2010 138, 2307-2314DOI: (10.1053/j.gastro.2010.02.009) Copyright © 2010 AGA Institute Terms and Conditions

Figure 4 Association between rs12979860 genotype and HCV genotype among 681 Caucasian chronic HCV patients from our cohort. Percentage of subjects carrying the rs12979860 CC genotype is shown with 95% confidence intervals. Chi-squared P value for association between HCV genotype (gt1, gt2, gt3) and rs12979860 CC vs CT/TT genotype is shown. Gastroenterology 2010 138, 2307-2314DOI: (10.1053/j.gastro.2010.02.009) Copyright © 2010 AGA Institute Terms and Conditions